Wasmuth, J-C <br/><br/>
Fatal acute liver failure due to reactivation of hepatitis B following treatment with fludarabine/cyclophosphamide/rituximab for low grade non-Hodgkin's lymphoma.  [electronic resource] 

 -  European journal of medical research  Oct 2008 
 - 483-6 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>0949-2321 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--adverse effects<br/>Antibodies, Monoclonal, Murine-Derived<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Cyclophosphamide--adverse effects<br/>Diagnosis, Differential<br/>Fatal Outcome<br/>Hepatitis B, Chronic--complications<br/>Humans<br/>Liver--pathology<br/>Liver Failure, Acute--etiology<br/>Lymphoma, Non-Hodgkin--drug therapy<br/>Male<br/>Middle Aged<br/>Recurrence<br/>Rituximab<br/>Vidarabine--adverse effects